Global knowledge mapping and emerging trends in research between spasmolytic polypeptide-expressing metaplasia and gastric carcinogenesis: A bibliometric analysis from 2002 to 2022.

bibliomeric analysis gastric carcinogenesis (SGC-7901) gastric precancerous lesions helicobacter pylori infection (H. pylori infection) spasmolytic polypeptide-expressing metaplasia (SPEM) visualization

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 26 11 2022
accepted: 28 12 2022
entrez: 13 2 2023
pubmed: 14 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Spasmolytic polypeptide expression metaplasia (SPEM) occurs in the corpus of the stomach and is closely related to inflammations caused by We searched the Web of Science Core Collection (WoSCC) for publications related to SPEM-GC from 2002 to 2022. The VOSviewer, SCImago, CiteSpace and R software were used to visualize and analyze the data. Gene targets identified in the keyword list were analyzed for functional enrichment using the KEGG and GO databases. Of the 292 articles identified in the initial search, we observed a stable trend in SPEM-GC research but rapid growth in the number of citations. The United States was the leader in terms of quality publications and international cooperation among them. The total number of articles published by Chinese scholars was second to the United States. Additionally, despite its low centrality and average citation frequency, China has become one of the world's most dynamic countries in academics. In terms of productivity, Vanderbilt University was identified as the most productive institution. Further, we also observed that Gastroenterology was the highest co-cited journal, and Goldenring Jr. was the most prolific author with the largest centrality. SPEM could serve as an initial step in diagnosing gastric precancerous lesions. Current hotspots and frontiers of research include SPEM cell lineage differentiation, interaction with

Sections du résumé

Background
Spasmolytic polypeptide expression metaplasia (SPEM) occurs in the corpus of the stomach and is closely related to inflammations caused by
Methods
We searched the Web of Science Core Collection (WoSCC) for publications related to SPEM-GC from 2002 to 2022. The VOSviewer, SCImago, CiteSpace and R software were used to visualize and analyze the data. Gene targets identified in the keyword list were analyzed for functional enrichment using the KEGG and GO databases.
Results
Of the 292 articles identified in the initial search, we observed a stable trend in SPEM-GC research but rapid growth in the number of citations. The United States was the leader in terms of quality publications and international cooperation among them. The total number of articles published by Chinese scholars was second to the United States. Additionally, despite its low centrality and average citation frequency, China has become one of the world's most dynamic countries in academics. In terms of productivity, Vanderbilt University was identified as the most productive institution. Further, we also observed that Gastroenterology was the highest co-cited journal, and Goldenring Jr. was the most prolific author with the largest centrality.
Conclusion
SPEM could serve as an initial step in diagnosing gastric precancerous lesions. Current hotspots and frontiers of research include SPEM cell lineage differentiation, interaction with

Identifiants

pubmed: 36776551
doi: 10.3389/fcimb.2022.1108378
pmc: PMC9912936
doi:

Substances chimiques

Peptides 0
spasmolytic polypeptide 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1108378

Informations de copyright

Copyright © 2023 Liu, Wang, Zhao, Zhang, Liu, Wang, Wang and Tang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Immunol. 2022 Aug 11;13:953465
pubmed: 36032148
Gastroenterology. 2020 Feb;158(3):598-609.e5
pubmed: 31589873
Cell Mol Gastroenterol Hepatol. 2022;13(1):199-217
pubmed: 34455107
Science. 2004 Nov 26;306(5701):1568-71
pubmed: 15567866
J Pathol. 2009 Mar;217(4):581-8
pubmed: 19090485
Gastroenterology. 2020 May;158(6):1650-1666.e15
pubmed: 32032583
Curr Med Chem. 2012;19(35):5975-83
pubmed: 22963573
Sci Prog. 2022 Jan-Mar;105(1):368504211029777
pubmed: 35220816
AMIA Annu Symp Proc. 2005;:724-8
pubmed: 16779135
Nat Cell Biol. 2017 Jul;19(7):774-786
pubmed: 28581476
Nat Med. 2002 Oct;8(10):1089-97
pubmed: 12219085
Gastroenterology. 2009 Apr;136(4):1288-96
pubmed: 19230855
Helicobacter. 2019 Jun;24(3):e12578
pubmed: 30990573
Gastroenterology. 2018 Dec;155(6):1852-1867
pubmed: 30195448
Cell Mol Gastroenterol Hepatol. 2017 Mar 14;4(1):55-63
pubmed: 28560289
Gastroenterology. 2019 Jan;156(1):160-174.e7
pubmed: 30287170
Gut. 2018 May;67(5):805-817
pubmed: 28196875
Gastroenterology. 2021 Sep;161(3):953-967.e15
pubmed: 34116028
J Pathol. 2018 Jun;245(2):132-137
pubmed: 29508389
Clin Microbiol Rev. 2010 Oct;23(4):713-39
pubmed: 20930071
Lab Invest. 1999 Jun;79(6):639-46
pubmed: 10378506
Trends Immunol. 2020 Aug;41(8):643-645
pubmed: 32605803
PLoS One. 2013 Jul 30;8(7):e70242
pubmed: 23936173
Mol Cell Biol. 2003 Dec;23(23):8429-39
pubmed: 14612389
EMBO J. 2018 Apr 3;37(7):
pubmed: 29467218
Int J Mol Sci. 2017 Sep 27;18(10):
pubmed: 28953255
J Pathol. 2020 Jul;251(3):336-347
pubmed: 32432338
Front Immunol. 2022 Aug 24;13:952546
pubmed: 36090978
Gastroenterology. 2018 Mar;154(4):839-843.e2
pubmed: 29248442
Cell Mol Gastroenterol Hepatol. 2017 Feb 20;3(3):331-338
pubmed: 28462375
Gastroenterology. 2005 Apr;128(4):935-45
pubmed: 15825076
Gastroenterology. 2021 Jan;160(1):302-316.e7
pubmed: 33010253
Front Immunol. 2022 Jun 13;13:917155
pubmed: 35769473
Cell Mol Gastroenterol Hepatol. 2016 Nov 16;3(1):11-26
pubmed: 28174755
J Cell Biol. 2002 May 27;157(5):761-70
pubmed: 12034770
Gastroenterology. 2013 Sep;145(3):554-65
pubmed: 23684942
Scientometrics. 2010 Aug;84(2):523-538
pubmed: 20585380
Gastroenterology. 2020 Dec;159(6):2116-2129.e4
pubmed: 32835664
Gastroenterology. 2010 Dec;139(6):2028-2037.e9
pubmed: 20854822
Cell Mol Gastroenterol Hepatol. 2015 Jan 03;1(2):203-221.e3
pubmed: 28210674
J Physiol. 2018 Sep;596(17):3861-3867
pubmed: 29427515
Cell Mol Gastroenterol Hepatol. 2017 Mar 23;4(1):85-88
pubmed: 28560292
J Biol Chem. 2010 Oct 29;285(44):33691-700
pubmed: 20736174
Gastroenterology. 2017 Mar;152(4):762-766.e7
pubmed: 27932312
Aliment Pharmacol Ther. 2013 May;37(10):969-78
pubmed: 23550594
Gastroenterology. 2022 Aug;163(2):411-425.e4
pubmed: 35487288
Nat Rev Gastroenterol Hepatol. 2018 May;15(5):257-273
pubmed: 29463907
Contemp Clin Trials. 2022 Feb;113:106665
pubmed: 34968767
Gut. 2020 Jun;69(6):1027-1038
pubmed: 31481545
Gastroenterology. 2016 Apr;150(4):918-30.e13
pubmed: 26677984
Int J Mol Sci. 2020 Jun 25;21(12):
pubmed: 32630599
Gastroenterology. 2004 Aug;127(2):582-94
pubmed: 15300590
Helicobacter. 2017 Aug;22(4):
pubmed: 28326664
Health Info Libr J. 2021 Jun;38(2):125-138
pubmed: 31995273
Exp Cell Res. 2011 Nov 15;317(19):2759-64
pubmed: 21907708
Gastroenterology. 2018 Mar;154(4):801-803
pubmed: 29425924
Gastroenterology. 2020 Dec;159(6):2077-2091.e8
pubmed: 32891625
Front Immunol. 2022 Jul 28;13:969217
pubmed: 35967367
Gastric Cancer. 2009;12(4):189-97
pubmed: 20047123
Lancet. 1975 Jul 12;2(7924):58-60
pubmed: 49653
Gastroenterology. 2011 Feb;140(2):412-24
pubmed: 21144849
Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15;307(8):G777-92
pubmed: 25190476
Cell Mol Gastroenterol Hepatol. 2016 May 17;2(5):605-624
pubmed: 27990460
Lancet. 2020 Aug 29;396(10251):635-648
pubmed: 32861308
Helicobacter. 2017 Feb;22(1):
pubmed: 27220894
Cancer Biol Ther. 2015;16(6):987-96
pubmed: 25901741
Gut Liver. 2017 Nov 15;11(6):789-797
pubmed: 28642451
Methods Mol Biol. 2016;1422:329-39
pubmed: 27246044
Curr Opin Gastroenterol. 2018 Nov;34(6):458-464
pubmed: 30138135
World J Gastroenterol. 2014 May 14;20(18):5191-204
pubmed: 24833849
Gastroenterology. 2008 Feb;134(2):511-22
pubmed: 18242217
J Pathol. 2019 Apr;247(4):513-523
pubmed: 30511397
Infect Immun. 2015 Dec 07;84(2):562-72
pubmed: 26644382
Nat Genet. 2014 Jun;46(6):573-82
pubmed: 24816253
J Pathol. 2016 Aug;239(4):399-410
pubmed: 27125972
Gastroenterology. 2004 Jan;126(1):196-207
pubmed: 14699500
PLoS One. 2017 Sep 13;12(9):e0184514
pubmed: 28902909
Gastroenterology. 2021 Jan;160(1):260-271.e10
pubmed: 32956680
Dig Dis Sci. 2003 Mar;48(3):431-41
pubmed: 12757153
Lab Invest. 2007 Dec;87(12):1265-76
pubmed: 18004396
J Pathol. 2017 Aug;242(4):463-475
pubmed: 28497484
Gastroenterology. 2022 Feb;162(2):415-430
pubmed: 34728185
J Med Genet. 2020 Jun;57(6):385-388
pubmed: 30877236
Mod Pathol. 2020 Oct;33(10):2075-2086
pubmed: 32269290
Gastroenterology. 2012 Feb;142(2):292-304
pubmed: 22079592
Nat Rev Dis Primers. 2017 Jun 01;3:17036
pubmed: 28569272
STAR Protoc. 2021 Sep 17;2(4):100814
pubmed: 34585155
Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G583-G596
pubmed: 29345968
Front Immunol. 2022 Aug 12;13:969196
pubmed: 36032149
Gastroenterology. 2022 Jul;163(1):154-162.e3
pubmed: 35364066

Auteurs

Lin Liu (L)

Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Yang Wang (Y)

Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Yukun Zhao (Y)

Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.

Wei Zhang (W)

Department of Pathology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Jiong Liu (J)

Department of Pathology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Fengyun Wang (F)

Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Ping Wang (P)

Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Xudong Tang (X)

Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH